Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 117 of the 118 references it cites were found in a registry or an index.

Targeting hypoxia cell signaling for cancer therapy

Melillo, Giovanni · 2007 · Cancer and Metastasis Reviews

Abstract

Hypoxia, a decrease in oxygen levels, is a hallmark of solid tumors. Hypoxic cells are more resistant to killing by ionizing radiation and chemotherapy, are more invasive and metastatic, resistant to apoptosis, and genetically unstable. Over the last two decades, the discovery of Hypoxia Inducible Factors, a family of transcription factors crucially involved in the response of mammalian cells to oxygen deprivation, has led to the identification of a molecular target associated with hypoxia suitable for the development of cancer therapeutics. These features of solid tumors may offer a unique opportunity for selective therapeutic approaches. A number of strategies targeting hypoxia and/or Hypoxia Inducible Factors (HIF) have been developed over the last several years and will be described. The exponentially growing interest in therapeutic strategies targeting hypoxia/HIF will undoubtedly generate more active compounds for preclinical and clinical development. A rational development plan aimed to validate target inhibition in preclinical models and early clinical trials is essential for a rapid translation of these agents to the treatment of human cancers.

Overview

Integrity signals

Registry

Crossref · 10.1007/s10555-007-9059-x

Cites

117 of 118 references verified0 citation errors · 1 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 117 references

Cited by

See all 230

Metadata

Authors
Melillo, G.
Affiliations
National Cancer Institute (US)
Corresponding author
Melillo, Giovanni
Venue
Cancer and Metastasis Reviews
Published
2007-04-06
Volume
26
Issue
2
Pages
341-352
ISSN
  • 0167-7659 (ISSN-L)
  • 1573-7233
OpenAlex
W2088397778
Cited by
230
References
117
Citations by year
2025: 4 · 2024: 2 · 2023: 8 · 2022: 3 · 2021: 10 · 2020: 9 · 2019: 4 · 2018: 5 · 2017: 8 · 2016: 14 · 2015: 13 · 2014: 10 · 2013: 12 · 2012: 21
FWCI
2.42
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Cancer and Metastasis Reviews (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (n01co12400-79-0-22)
  • National Cancer Institute (N01CO12400)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
Keywords
tumor hypoxia, hypoxia-inducible factor, HIF inhibitors, cancer therapy, solid tumors, radiosensitization, chemoresistance, metastasis, apoptosis resistance, genomic instability, drug development
MeSH terms
Animals, Antineoplastic Agents, Cell Division, Humans, Neoplasm Transplantation, Neoplasms, Oxygen Consumption, Transplantation, Heterologous, Signal Transduction, Cell Hypoxia, Hypoxia-Inducible Factor 1, alpha Subunit

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Targeting hypoxia cell signaling for cancer therapy. https://app.cochat.ai/papers/10.1007/s10555-007-9059-x
The paper
Melillo, G. (2007). Targeting hypoxia cell signaling for cancer therapy. Cancer and Metastasis Reviews. https://doi.org/10.1007/s10555-007-9059-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.